Alexion Pharmaceuticals Inc ALXN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/13/21 EDT
153.73quote price arrow up+153.73 (UNCH)
Volume
38,507
Close
153.73quote price arrow down-0.28 (-0.18%)
Volume
1,041,190
52 week range
94.82 - 162.60

...

Loading . . .
  • Open153.85
  • Day High154.51
  • Day Low153.01
  • Prev Close153.73
  • 52 Week High162.60
  • 52 Week High Date01/26/21
  • 52 Week Low94.82
  • 52 Week Low Date05/06/20

Key Stats

  • Market Cap33.798B
  • Shares Out219.85M
  • 10 Day Average Volume1.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-1.61

KEY STATS

  • Open153.85
  • Day High154.51
  • Day Low153.01
  • Prev Close153.73
  • 52 Week High162.60
  • 52 Week High Date01/26/21
  • 52 Week Low94.82
  • 52 Week Low Date05/06/20
  • Market Cap33.798B
  • Shares Out219.85M
  • 10 Day Average Volume1.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-1.61

RATIOS/PROFITABILITY

  • EPS (TTM)2.69
  • P/E (TTM)57.06
  • Fwd P/E (NTM)11.63
  • EBITDA (MRQ)3.128B
  • ROE (MRQ)5.26%
  • Revenue (MRQ)6.07B
  • Gross Margin (MRQ)90.88%
  • Net Margin (MRQ)9.94%
  • Debt To Equity (MRQ)21.99%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Alexion Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company’s marketed products include SOLIRIS (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa), ULTOMIRIS, Andexxa and Ondexxya. The Company’s clinical development programs include ALXN1210, ALXN1810, ALXN1720, ALXN1830, ALXN1840 and ABY-039. The Company’s ULTOMIRIS is a long-acting C5 inhibitor discovered and...
David Brennan
Chairman
Ludwig Hantson Ph.D.
Chief Executive Officer
Aradhana Sarin M.D.
Chief Financial Officer
Brian Goff
Executive Vice President
John Orloff
Executive Vice President
Address
121 Seaport Blvd
Boston, MA
02210-2050
United States

Top Peers

SYMBOLLASTCHG%CHG
GRFS
Grifols SA
17.85+0.34+1.94%
REGN
Regeneron Pharmaceuticals Inc
477.04+4.24+0.90%
SGEN
Seagen Inc
140.89+0.17+0.12%
SYNH
Syneos Health Inc
78.83-0.32-0.40%
INCY
Incyte Corp
80.65+0.78+0.98%